Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial
View abstract on PubMed
Summary
This summary is machine-generated.A combination of aspirin, calcitriol, and calcium carbonate did not prevent colorectal adenoma recurrence in a 3-year trial. Smoking status may influence treatment effects, but overall results were not significant.
Area Of Science
- Gastroenterology
- Oncology
- Preventive Medicine
Background
- Colorectal adenoma recurrence and colorectal cancer incidence are significant health concerns.
- Chemoprevention strategies are explored to mitigate these risks.
- Previous research suggests potential roles for aspirin, calcitriol, and calcium carbonate.
Purpose Of The Study
- To evaluate the efficacy of a combination therapy including acetylsalicylic acid (aspirin), calcitriol, and calcium carbonate in preventing colorectal adenoma recurrence.
- To assess secondary outcomes such as advanced adenomas, adenoma burden, and size.
Main Methods
- A randomized, double-blind, placebo-controlled trial involving 1107 patients with a history of colorectal adenoma removal.
- Participants received either the combination therapy or a placebo daily for 3 years.
- Adenoma recurrence was assessed via colonoscopy after 3 years; secondary outcomes were also monitored.
Main Results
- The trial was terminated early due to futility, with no significant difference in adenoma recurrence rates between the treatment and placebo groups.
- No significant differences were observed in adverse effects or secondary outcomes.
- Subgroup analyses suggested a potential interaction with smoking status, though not statistically significant overall.
Conclusions
- The combination of calcitriol, aspirin, and calcium carbonate did not demonstrate efficacy in preventing colorectal adenoma recurrence over a 3-year period.
- Negative findings may be attributed to smoking effects or suboptimal dosages of the agents used.
- Further research is warranted to explore chemopreventive strategies for colorectal adenomas.